IBDEI0VT ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32004,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,32004,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,32005,0)
 ;;=E20.0^^119^1556^34
 ;;^UTILITY(U,$J,358.3,32005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32005,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,32005,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,32005,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,32006,0)
 ;;=E20.9^^119^1556^30
 ;;^UTILITY(U,$J,358.3,32006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32006,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,32006,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,32006,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,32007,0)
 ;;=E23.0^^119^1556^31
 ;;^UTILITY(U,$J,358.3,32007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32007,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,32007,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,32007,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,32008,0)
 ;;=E27.1^^119^1556^51
 ;;^UTILITY(U,$J,358.3,32008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32008,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,32008,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,32008,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,32009,0)
 ;;=E27.2^^119^1556^1
 ;;^UTILITY(U,$J,358.3,32009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32009,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,32009,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,32009,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,32010,0)
 ;;=E27.3^^119^1556^23
 ;;^UTILITY(U,$J,358.3,32010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32010,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,32010,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,32010,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,32011,0)
 ;;=E29.1^^119^1556^52
 ;;^UTILITY(U,$J,358.3,32011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32011,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,32011,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,32011,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,32012,0)
 ;;=E55.9^^119^1556^59
 ;;^UTILITY(U,$J,358.3,32012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32012,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,32012,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,32012,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,32013,0)
 ;;=E66.01^^119^1556^38
 ;;^UTILITY(U,$J,358.3,32013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32013,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,32013,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,32013,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,32014,0)
 ;;=E66.8^^119^1556^42
 ;;^UTILITY(U,$J,358.3,32014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32014,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,32014,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,32014,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,32015,0)
 ;;=E66.9^^119^1556^43
 ;;^UTILITY(U,$J,358.3,32015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32015,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,32015,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,32015,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,32016,0)
 ;;=E74.39^^119^1556^35
 ;;^UTILITY(U,$J,358.3,32016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32016,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,32016,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,32016,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,32017,0)
 ;;=E83.30^^119^1556^46
 ;;^UTILITY(U,$J,358.3,32017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32017,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,32017,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,32017,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,32018,0)
 ;;=E83.51^^119^1556^28
 ;;^UTILITY(U,$J,358.3,32018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32018,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,32018,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,32018,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,32019,0)
 ;;=E83.52^^119^1556^26
 ;;^UTILITY(U,$J,358.3,32019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32019,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,32019,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,32019,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,32020,0)
 ;;=E87.5^^119^1556^27
 ;;^UTILITY(U,$J,358.3,32020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32020,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,32020,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,32020,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,32021,0)
 ;;=E89.2^^119^1556^48
 ;;^UTILITY(U,$J,358.3,32021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32021,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,32021,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,32021,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,32022,0)
 ;;=E89.6^^119^1556^47
 ;;^UTILITY(U,$J,358.3,32022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32022,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,32022,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,32022,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,32023,0)
 ;;=L68.0^^119^1556^25
 ;;^UTILITY(U,$J,358.3,32023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32023,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,32023,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,32023,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,32024,0)
 ;;=M80.00XA^^119^1556^2
 ;;^UTILITY(U,$J,358.3,32024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32024,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,32024,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,32024,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,32025,0)
 ;;=M81.0^^119^1556^3
 ;;^UTILITY(U,$J,358.3,32025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32025,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,32025,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,32025,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,32026,0)
 ;;=M85.80^^119^1556^44
 ;;^UTILITY(U,$J,358.3,32026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32026,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,32026,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,32026,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,32027,0)
 ;;=N62.^^119^1556^24
 ;;^UTILITY(U,$J,358.3,32027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32027,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,32027,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,32027,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,32028,0)
 ;;=E10.43^^119^1556^6
 ;;^UTILITY(U,$J,358.3,32028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32028,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,32028,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,32028,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,32029,0)
 ;;=E10.59^^119^1556^4
 ;;^UTILITY(U,$J,358.3,32029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32029,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,32029,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,32029,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,32030,0)
 ;;=E10.618^^119^1556^5
 ;;^UTILITY(U,$J,358.3,32030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32030,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,32030,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,32030,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,32031,0)
 ;;=E10.621^^119^1556^7
 ;;^UTILITY(U,$J,358.3,32031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32031,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,32031,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,32031,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,32032,0)
 ;;=E10.622^^119^1556^11
 ;;^UTILITY(U,$J,358.3,32032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32032,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,32032,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,32032,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,32033,0)
 ;;=E10.65^^119^1556^10
 ;;^UTILITY(U,$J,358.3,32033,1,0)
 ;;=^358.31IA^4^2
